文献速递乳腺介入US乳腺X线

碳酸氢钠缓冲利多卡因对影像引导乳腺活检患者疼痛的影响

Impact of Sodium Bicarbonate-Buffered Lidocaine on Patient Pain During Image-Guided Breast Biopsy.
PubMed 文献 · J Am Coll Radiol · 2017-05-17

这项随机双盲对照研究将85名接受超声或立体定向引导空芯针乳腺活检的女性随机分为碳酸氢钠缓冲利多卡因组和单纯利多卡因对照组,评估麻醉注射及组织取样时的疼痛。结果显示缓冲利多卡因显著降低了实质内注射疼痛,并在特定亚组中进一步降低皮内注射、实质内注射及组织取样疼痛。

要点

  • 实质内注射时缓冲组平均疼痛评分1.84 vs 对照组2.98(P=.03),差异有统计学意义。
  • 术前有疼痛者皮内注射疼痛缓冲组0.85±1.23 vs 对照组2.50±2.09;脂肪型或散在纤维腺体组织者实质内注射疼痛缓冲组1.35±1.95 vs 对照组3.52±3.13。
  • 超声引导活检组织取样疼痛缓冲组0.23±0.63 vs 对照组1.79±3.05。

核心结论

  • 总体而言,碳酸氢钠缓冲利多卡因显著降低了实质内注射时的疼痛,并在特定患者亚组的皮内注射、实质内注射及组织取样中进一步降低疼痛。

研究设计与样本

  • 前瞻性、符合HIPAA的随机双盲对照研究,85名接受超声或立体定向引导空芯针乳腺活检的女性随机接受1%利多卡因与碳酸氢钠按9:1比例缓冲(缓冲组)或单纯1%利多卡因(对照组),采用0至10 Likert疼痛量表评估皮内注射、实质内注射及组织取样时的疼痛。

诊断标准与关键数值

  • 未调整平均疼痛评分:皮内注射缓冲组1.47 vs 对照组2.07(P=.15),实质内注射缓冲组1.84 vs 对照组2.98(P=.03),组织取样缓冲组0.81 vs 对照组1.71(P=.07)。
  • 术前有疼痛者皮内注射疼痛:缓冲组0.85±1.23 vs 对照组2.50±2.09。
  • 脂肪型或散在纤维腺体组织者实质内注射疼痛:缓冲组1.35±1.95 vs 对照组3.52±3.13。
  • 超声引导活检组织取样疼痛:缓冲组0.23±0.63 vs 对照组1.79±3.05。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: This randomized, double-blind controlled study evaluated the effectiveness of sodium bicarbonate-buffered lidocaine on reducing pain during imaging-guided breast biopsies.

MATERIALS AND METHODS: This prospective, HIPAA-compliant study randomly assigned 85 women undergoing ultrasound- or stereotactic-guided core-needle breast biopsies to receive intradermally and intraparenchymally either 1% lidocaine buffered with sodium bicarbonate (9:1 ratio) (bicarbonate study group) or 1% lidocaine alone (control group). Pain was evaluated using a 0-to-10 Likert pain scale during both intradermal and intraparenchymal anesthesia injections and during tissue sampling. Prebiopsy breast pain, anxiety, medical history, demographics, biopsy type, radiologist level of training, breast density, and lesion histology were recorded. Data were analyzed using analysis of variance and analysis of covariance.

RESULTS: Unadjusted mean pain scores were 1.47 and 2.07 (study and control groups, respectively; P = .15) during intradermal injections, and 1.84 and 2.98 (study and control groups, respectively; P = .03) during intraparenchymal injections. Tissue sampling mean pain scores were .81 and 1.71 (study and control groups, respectively; P = .07). Moderator analyses found (1) among patients with preprocedural pain, those in the bicarbonate group experienced less intradermal injection pain (0.85 ± 1.23) than patients in the control group (2.50 ± 2.09); (2) among patients with fatty or scattered fibroglandular tissue, those in the bicarbonate group (1.35 ± 1.95) experienced less intraparenchymal injection pain than the control group (3.52 ± 3.13); and (3) during ultrasound-guided biopsies, patients in the bicarbonate group experienced less tissue-sampling pain (0.23 ± 0.63) than the control group (1.79 ± 3.05).

CONCLUSIONS: Overall, buffering lidocaine with sodium bicarbonate significantly reduced pain during intraparenchymal injections, and additional pain reduction was found in certain patient subgroups during intradermal injections, intraparenchymal injections, and tissue sampling.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Vasan A, Baker JA, Shelby RA, et al. Impact of Sodium Bicarbonate-Buffered Lidocaine on Patient Pain During Image-Guided Breast Biopsy. J Am Coll Radiol. 2017. PMID: 28527821. doi:10.1016/j.jacr.2017.03.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。